(Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, December 8, 2024, at 8:00 p.m. PT (11:00 p.m. ET) during the 66th American Society of ...

Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s ...

(Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, December 8, 2024, at 8:00 p.m. PT (11:00 p.m. ET) during the 66th American Society of ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

PharmAla Biotech Holdings Inc. MDXXF has announced that it will supply its Good Manufacturing Practice LaNeo MDMA for a clinical trial at Mt. Sinai Health System. The biotechnology company ...

Even during this tense election year, bipartisan coalitions are taking steps to enhance national security, protect American ... the domestic supply chain that renders robust biotech innovation ...

China, November 20, 2023. The president of American Battery Factory Inc. says the U.S. battery supply chain needs to be improved. (Photo by Costfoto/NurPhoto via Getty Images) The supply chain for ...

Syngene (CMP: Rs 875; Market cap: Rs 35,216 crore; Rating: Overweight), the leading CRAMS (contract research and manufacturing services) player, posted a sequential growth in its Q2FY25 results.

“In a rapidly changing world, this facility will help generate new knowledge and skills, contributing to a national biotech supply chain that attracts and retains the best global talents.” Technical ...

Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise. Bright Minds shares DRUG ...

The deal, which features $1.1 billion in milestones, covers the global rights to a small molecule discovered by a Chinese biotech that has built a business around botanical drugs. Baiyu has spent ...